Skip to main content

Patents

Our Patents

Guided by its strategic vision, the Libyan Biotechnology Research Center places the protection of intellectual property at the forefront of its priorities, as a key driver for strengthening the national innovation ecosystem and advancing scientific excellence. The Center continues to lead in delivering high-impact research outputs across modern fields of knowledge and emerging technologies.

Patents represent a fundamental pillar in transforming laboratory-based innovations into tangible, practical applications that serve society and support the national economy. In pursuit of this vision, the Center is committed to fostering a stimulating research environment that empowers innovators to translate their ideas into valuable technological solutions, while ensuring that these innovations are properly documented and protected at both the national and international levels.

These sustained efforts have been recognized through the successful registration of a series of patents aligned with the Center’s approved research priorities. This achievement reflects the Center’s dedication to advancing from academic research toward productive applied research, and to reinforcing innovation as a cornerstone of national industrial development.

claiming priority

The Libyan Biotechnology Research Center has been granted priority registration certificates for a number of patent applications by the Industrial Property Office of the Industrial Research Center in Tripoli.
The registered patent applications are listed as follows:

  • This invention introduces an AI-based web system designed to recognize COVID-19 cases in Libya using medical imaging.

    Registered under No. 42/55/2020.

The patent presents a technique for storing amniotic membrane grafts while protecting them from free-radical formation.

Registered under No. 3859/2025.

A specialized method developed for the propagation and cultivation of the fennel plant.

Registered under No. 39/59/2025.

This invention provides a locally sourced plant-based food formula for rearing Ceratitis capitata larvae.

Registered under No. 40/59/5025.

A nanometric lipid-based Praziquantel capsule proposed as a potential single-dose oral treatment for schistosomiasis.

Registered under No. 41/59/2025.

This patent describes solid lipid nanoparticles formulated with wheat germ oil.

Registered under No. 42/59/2025.

A method for purifying flavonoids through immobilized metal ion affinity chromatography (IMAC).

Registered under No. 53/59/2025.

This invention presents a plant extract with anticoagulant properties.

Registered under No. 78/59/2025.

International Priority Registration –USPTO

The Libyan Biotechnology Research Center has obtained an international priority registration certificate from the United States Patent and Trademark Office (USPTO) for a research innovation developed by the Human Tissue Department, entitled:

Amniotic Membrane Preservation and Free Radical Control Post Gamma Irradiation

Priority Registration Date: 28 January 2026